Primitive human hematopoietic precursors express Bcl-x but not Bcl-2

Blood

Volumn 86, Issue 3, 1995, Pages 868-876

  Park, Julie R ^a   Bernstein, Irwin D ^b   Hockenbery, David M ^b  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL SURVIVAL; COLONY FORMING CELL; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MONONUCLEAR CELL; PRIORITY JOURNAL; REPRESSOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029156492     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.3.868.bloodjournal863868     Document Type: Article

References (54)

1. Savill J, Wyllie A, Walport M, Henson P, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation: Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865, 1989
2. Williams G, Smith C, Spooncer E, Dexter T, Taylor D: Hematopoietic colony stimulating factors promote survival by suppressing apoptosis. Nature 343:76, 1990
3. Koury M, Bondurant M: Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid progenitor cells. Science 248:378, 1990
4. Lopez A, Williamson J, Gamble J, Begley C, Harlan J, Klebanoff S, Walerdorph A, Wong G, Clark S, Vadas M: Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro human neutrophil and eosinophil function, surface receptor expression and survival. J Clin Invest 78:1220, 1986
5. Mangan D, Wahl S: Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cytokines. J Immunol 147:3408, 1991
6. Yamaguchi Y. Suda T, Oath S, Tominaga K, Miura Y, Kashara T: Analysis of the survival of mature eosinophils: Interleukin-5 prevents apoptosis in mature eosinophils. Blood 78:2542, 1991
7. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovi: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012, 1992
8. Koury M: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391, 1992
9. Dexter T, Spooncer E, Toksoz D, Lajtha L: The role of cells and their products in the regulation of in vitro stem cell proliferation and granulocyte development. J Supramol Struc 13:513, 1980
10. Sutherland H, Eaves C, Eaves A, Dragowska W, Lansdorp P: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
11. Fraser C, Szilvassy S, Eaves J, Humphries R: Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability. Proc Natl Acad Sci USA 89:1968, 1992
12. Civin C, Strauss L, Brovall C, Fackler M, Schwartz S, Shaper S: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor surface antigen defined by a monoclonal antibody raised against KG-la cells. J Immunol 133:157, 1984
13. Andrews R, Singer J, Bernstein I: Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842, 1986
14. Berenson R, Andrews R, Bensinger W, Kalamasz D, Knitter G, Buckner C, Bernstein I: Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951, 1988
15. Andrews R, Singer J, Bernstein I: Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721, 1989
16. Bertoncello I, Hodgson G, Bradley T: Multiparameter analysis of transplantable hematopoietic stem cells. I. The separation and enrichment of stem cells homing to marrow and spleen on the basis rhodamine-123 fluorescence. Exp Hematol 1985:999, 1985
17. Udomsakdi C, Eaves C, Sutherland H, Lansdorp P: Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol 19:338, 1991
18. Baum C, Weissman I, Tsukamoto A, Buckle A, Peault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804, 1992
19. Andrews R, Singer J, Bernstein I: Human hematopoietic precursors in long-term culture: Single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colonyforming cells when cultured with marrow stromal cells. J Exp Med 172:355, 1990
20. Andrews R, Bryant E, Bartelmez S, Muirhead D, Knitter G, Bensinger W, Strong D, Bernstein I: CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 80:1, 1992
21. Terstappen L, Huang S, Safford M, Lansdorp P, Loken M: Sequential generation of hematopoietic colonies derived from single nonlineage-committed CD34+ CD38- progenitor cells. Blood 77:1218, 1991
22. Huang S, Terstappen L: Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. Blood 83:1515, 1994
23. Boise L, Gonzales-Garcia M, Postema C, Ding L, Lindsten T, Turka L, Mao X, Nunez G, Thompson C: Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
24. Oltvai Z, Milliman C, Korsmeyer S: Bcl-2 heterodimerizes in vivo with a conserved homologue, bax, that accelerates programmed cell death. Cell 74:1, 1993
25. Tsujimoto Y, Finger L, Yunis J, Nowell P, Croce C: Cloning the chromosome breakpoint of neoplastic B-cells with the t(14; 18) chromosome translocation. Science 226:1097, 1984
26. Bakhshi A, Jensen J, Goldman P, Wright J, McBride O, Epstein A, Korsmeyer S: Cloning the chromosomal breakpoint of t(14; 18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899, 1985
27. Cleary M, Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439, 1985
28. Hockenbery D, Nunez G, Milliman C, Schreiber R, Korsmeyer S: Bcl-2 protein is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
29. Chen-Levy Z, Nourse F, Cleary M: The Bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14; 18). Mol Cell Biol 9:701, 1989
30. Krajewski S, Tanaka S, Takayama S, Schibler M, Fenton W, Reed J: Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701, 1993
31. Jacobson M, Burne J, King M, Miyashita T, Reed J, Raff M: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365, 1993
32. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer S: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991
33. Delia D, Aiello A, Soligo D, Fontella E, Melani C, Pezzella F, Pierotti M, Della Porta G: Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291, 1992
34. Vaux D, Cory S, Adams J: Bcl-2 gene promotes hemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
35. Nunez G, London L, Hockenbery D, Alexander M, McKearn K, Korsmeyer S: Deregulated Bcl-2 gene expression selectively prolongs survival of growth facto-deprived hematopoietic cell lines. J Immunol 144:3602, 1990
36. Fairbairn L, Cowling G, Reipert B, Dexter T: Suppression of apoptosis allows differentiation and development of a multipotent hematopoietic cell line in the absence of added growth factors. Cell 74:823, 1993
37. Lagasse E, Weissman I: Bcl-2 inhibits apoptosis of neutrophilsbut not their engulfment by macrophages. J Exp Med 179:1047, 1994
38. Park J, Robertson K, Hickstein D, Tsai S, Hockenbery D, Collins S: Dysregulated Bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84:440, 1994
39. Krajewski S, Krajewski M, Wang H, Irie S, Fong L, Reed J: Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res 54:5501, 1994
40. Litzow M, Brashem-Stein C, Andrews R, Berstein I: Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9. Blood 77:2354, 1991
41. Pike B, Robinson W: Human bone marrow colony growth in agar gel. J Cell Physiol 76:77, 1970
42. Gottschalk A, Boise L, Thompson C, Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91:7350, 1994
43. Snoeck H, Van Bockstaele D, Nys G, Lenjou M, Lardon F, Haenan L, Rodrigus I, Peetermans M, Berneman Z: Interferongamma selectively inhibits very primitive CD34++ CD38+ human hematopoietic progenitor cells. J Exp Med 180:1177, 1994
44. LeBrun D, Warnke R, Cleary M: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743, 1993
45. McDonnel T, Deane N, Platt F, Nunez G, Jaeger U, McKearn J, Korsmeyer S: Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1989
46. Berardi A, Wang A, Levine J, Lopez P, Scadden D: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
47. Ramon y Cajal S: Histologie du Systeme Nerveux de l'Home et des Vertebres. Maloine, Paris, France, 1911
48. Kuhar S, Feng L, Vidan S, Ross M, Haten M, Heintz N: Changing patterns of gene expression define four stages of cerebellar granule neuron differentiation. Development 117:97, 1993
49. Merry D, Veis D, Hickey W, Korsmeyer S: Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301, 1994
50. Veis D, Sorenson C, Shutter J, Korsmeyer S: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229, 1993
51. Motoyama N, Wang F, Roth K, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Satoshi F, Loh D: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506, 1995
52. Yin X, Oltvai Z, Korsmeyer S: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321, 1994
53. Sato T, Hanada M, Bopdrug S, Irie S, Iwama N, Boise L, Thompson C, Golemis E, Fong L, Wang H, Reed J: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system, Proc Natl Acad Sci USA 91:9238, 1994
54. Yang E, Zha J, Jockel J, Boise L, Thompson C, Korsmeyer S: Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 80:285, 1995